Final results from a phase I trial and expansion cohorts of cabozantinib and nivolumab (CaboNivo) alone or with ipilimumab (CaboNivoIpi) for metastatic genitourinary tumors.

被引:6
|
作者
Apolo, Andrea B. [1 ]
Girardi, da Motta Daniel [1 ]
Niglio, Scot Anthony [1 ]
Nadal, Rosa Maria [2 ]
Cordes, Lisa M. [2 ]
Steinberg, Seth M. [3 ]
Costello, Rene
Trepel, Jane B. [4 ]
Lee, Sunmin
Lee, Min-Jung [5 ]
Cao Liang [6 ]
Gulley, James L. [1 ]
Bottaro, Donald P. [7 ]
Saraiya, Biren [8 ,9 ]
Pal, Sumanta K. [10 ]
Quinn, David, I [11 ]
Lara, Primo Lucky N. [12 ]
Parnes, Howard L. [1 ]
Dahut, William L. [13 ]
Mortazavi, Amir [14 ]
机构
[1] NCI, NIH, Bethesda, MD 20892 USA
[2] NIH, Bldg 10, Bethesda, MD 20892 USA
[3] NCI, Biostat & Data Management Sect, NIH, Bethesda, MD 20892 USA
[4] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[5] NCI, Dev Therapeut Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[6] NCI, Genet Branch, Ctr Canc Res, Bethesda, MD 20892 USA
[7] Ctr Canc Res, Div Canc Treatment & Diag, Bethesda, MD USA
[8] Rutgers Canc Inst New Jersey, Div Med Oncol, New Brunswick, NJ USA
[9] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA
[10] City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut, Duarte, CA USA
[11] USC Norris Canc Hosp, Los Angeles, CA USA
[12] Univ Calif, Sacramento, CA USA
[13] NCI, Bethesda, MD 20892 USA
[14] Ohio State Univ, Wexner Med Ctr, Arthur G James Canc Hosp, Columbus, OH 43210 USA
关键词
D O I
10.1200/JCO.2021.39.6_suppl.3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Phase 1/1b trial of fruquintinib in patients with advanced solid tumors: Preliminary results of the dose expansion cohorts in refractory metastatic colorectal cancer
    Dasari, Arvind
    Hubbard, Joleen M.
    Eng, Cathy
    Yeckes-Rodin, Heather
    Ukrainskyj, Stacey M.
    Yang, Zhao
    Schelman, William R.
    Kania, Marek K.
    Bekaii-Saab, Tanios S.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [32] Phase I expansion cohort trial to investigate the safety and clinical activity of avelumab (MSB0010718C) in patients with metastatic or locally advanced solid tumors.
    Heery, Christopher Ryan
    Infante, Jeffrey R.
    Iannotti, Nicholas
    Kelly, Karen
    Nikolinakos, Petros
    von Heydebreck, Anja
    Chin, Kevin M.
    Gulley, James L.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Interim results from the OPTIMAL trial: A phase II clinical trial of combination nivolumab, ipilimumab, and taxane in patients with untreated metastatic non-small cell lung cancer (NSCLC).
    Clarke, Jeffrey Melson
    Wang, Xiaofei F.
    Gu, Lin
    Stevenson, Marvaretta Miesha
    Stinchcombe, Tom
    Ramalingam, Sundhar
    Antonia, Scott Joseph
    Shariff, Afreen
    Garst, Jennifer
    Crawford, Jeffrey
    Ready, Neal E.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] EFFICACY AND SAFETY OF SOCAZOLIMAB IN RECURRENT OR METASTATIC CERVICAL CANCER: RESULTS FROM THE PHASE I TRIAL FOLLOWED BY AN EXPANSION STUDY
    An, J.
    Tang, J.
    Xiong, H.
    Qiu, H.
    Luo, L.
    Wang, L.
    Wang, D.
    Zhou, Q.
    Xu, Q.
    Song, H.
    Zhang, Y.
    Zhang, H.
    Li, G.
    Wu, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A8 - A8
  • [35] IMMUNOMODULATORY RESPONSE TO NEOADJUVANT NIVOLUMAB IN NON-METASTATIC CLEAR CELL RENAL CELL CARCINOMA: RESULTS FROM A PHASE I TRIAL
    Singla, Nirmish
    Nirschl, Thomas
    Obradovic, Aleksandar
    Shenderov, Eugene
    Lombardo, Kara
    Liu, Xiaopu
    Pons, Alice
    Zarif, Jelani
    Rowe, Steven
    Trock, Bruce
    Hammers, Hans
    Bivalacqua, Trinity
    Pierorazio, Phillip
    Deutsch, Julie
    Lotan, Tamara
    Taube, Janis
    Ged, Yasser
    Gorin, Michael
    Allaf, Mohamad
    Drake, Charles
    JOURNAL OF UROLOGY, 2023, 209 : E1119 - E1120
  • [36] Nivolumab plus ipilimumab plus cabozantinib triplet combination for patients with previously untreated advanced renal cell carcinoma: Results from a discontinued arm of the phase III CheckMate 9ER trial
    Apolo, Andrea B.
    Powles, Thomas
    Escudier, Bernard
    Burotto, Mauricio
    Zhang, Joshua
    Simsek, Burcin
    Scheffold, Christian
    Motzer, Robert J.
    Choueiri, Toni K.
    EUROPEAN JOURNAL OF CANCER, 2022, 177 : 63 - 71
  • [37] AIDS malignancy consortium (AMC) 095: A phase I study of ipilimumab (IPI) and nivolumab (NIVO) in advanced HIV-associated solid tumors (ST) with expansion cohorts in HIV-associated solid tumors and classical Hodgkin lymphoma (cHL).
    Rajdev, Lakshmi
    Chiao, Elizabeth
    Lensing, Shelly
    Streicher, Howard
    Little, Richard F.
    Dittmer, Dirk
    Einstein, Mark
    Haigentz, Missak
    Sparano, Joseph A.
    Mitsuyasu, Ronald T.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [38] Efficacy and safety results from a phase III trial of nivolumab (NIVO) alone or combined with ipilimumab (IPI) versus IPI alone in treatment-naive patients (pts) with advanced melanoma (MEL) (CheckMate 067).
    Wolchok, Jedd D.
    Chiarion-Sileni, Vanna
    Gonzalez, Rene
    Rutkowski, Piotr
    Grob, Jean Jacques
    Cowey, Charles Lance
    Lao, Christopher D.
    Schadendorf, Dirk
    Ferrucci, Pier Francesco
    Smylie, Michael
    Dummer, Reinhard
    Hill, Andrew Graham
    Haanen, John B. A. G.
    Maio, Michele
    McArthur, Grant A.
    Yang, Arvin
    Rollin, Linda
    Horak, Christine E.
    Larkin, James M. G.
    Hodi, F. Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [39] Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study
    Slovin, S. F.
    Higano, C. S.
    Hamid, O.
    Tejwani, S.
    Harzstark, A.
    Alumkal, J. J.
    Scher, H. I.
    Chin, K.
    Gagnier, P.
    McHenry, M. B.
    Beer, T. M.
    ANNALS OF ONCOLOGY, 2013, 24 (07) : 1813 - 1821
  • [40] Efficacy and safety results from a phase III trial of nivolumab (NIVO) alone or combined with ipilimumab (IPI) versus IPI alone in treatment-naive patients (pts) with advanced melanoma (MEL) (CheckMate 067)
    Wolchok, Jedd D.
    Chiarion-Sileni, Vanna
    Gonzalez, Rene
    Rutkowski, Piotr
    Grob, Jean Jacques
    Cowey, Charles Lance
    Lao, Christopher D.
    Schadendorf, Dirk
    Ferrucci, Pier Francesco
    Smylie, Michael
    Dummer, Reinhard
    Hill, Andrew Graham
    Haanen, John B. A. G.
    Maio, Michele
    McArthur, Grant A.
    Yang, Arvin
    Rollin, Linda
    Horak, Christine E.
    Larkin, James M. G.
    Hodi, F. Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (18)